Keymed Biosciences Inc

02162

Company Profile

  • Business description

    Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. Its clinical-stage drug candidates include CM310, CM326, CM313, and CM336 among others. The company is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it generates a majority of its revenue from overseas markets and the rest from Mainland China.

  • Contact

    No. 18 BioTown Middle Road
    Building D2
    Tianfu International BioTown, Chengdu
    Sichuan610219
    CHN

    T: +86 2888610620

    https://www.keymedbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1,258

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,830.1052.200.59%
CAC 407,878.46111.751.44%
DAX 4024,549.56342.651.42%
Dow JONES (US)44,458.30217.540.49%
FTSE 1008,867.0212.840.15%
HKSE23,947.5155.190.23%
NASDAQ20,611.34192.870.94%
Nikkei 22539,553.17268.11-0.67%
NZX 50 Index12,760.208.41-0.07%
S&P 5006,263.2637.740.61%
S&P/ASX 2008,591.9053.300.62%
SSE Composite Index3,512.0218.970.54%

Market Movers